Literature DB >> 18462844

IL-15 as memory T-cell adjuvant for topical HIV-1 DermaVir vaccine.

Sandra A Calarota1, Anlan Dai, Jeffrey N Trocio, David B Weiner, Franco Lori, Julianna Lisziewicz.   

Abstract

IL-7 and IL-15 are key cytokines involved in the generation and maintenance of memory CD8+ T-cells. We evaluated these cytokines as molecular adjuvants for topical HIV-1 DermaVir vaccine. We found that mice receiving DermaVir formulated with HIV-1 Gag plasmid in the presence of IL-7- or IL-15-encoding plasmid significantly enhanced Gag-specific central memory T-cells, as measured by a peptide-based cultured IFN-gamma ELISPOT. Additionally, IL-15 significantly improved DermaVir-induced Gag-specific effector memory CD8+ T-cell responses, measured by standard IFN-gamma ELISPOT. In a DermaVir prime/vaccinia vector boost regimen, the inclusion of IL-15 together with DermaVir significantly improved Gag-specific effector memory T-cell responses. Our study demonstrates that IL-15 is more potent than IL-7 in enhancing HIV-1-specific central memory T-cells induced by topical DermaVir. IL-15 adjuvanted DermaVir might be an alternative prime in a prophylactic vaccine regimen.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18462844      PMCID: PMC2582635          DOI: 10.1016/j.vaccine.2008.03.067

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  45 in total

1.  DermaVir, a novel HIV immunisation technology.

Authors:  Franco Lori; Jeffrey Trocio; Nyasha Bakare; Laurene M Kelly; Julianna Lisziewicz
Journal:  Vaccine       Date:  2005-03-18       Impact factor: 3.641

2.  CD8 positive T cells influence antigen-specific immune responses through the expression of chemokines.

Authors:  J J Kim; L K Nottingham; J I Sin; A Tsai; L Morrison; J Oh; K Dang; Y Hu; K Kazahaya; M Bennett; T Dentchev; D M Wilson; A A Chalian; J D Boyer; M G Agadjanyan; D B Weiner
Journal:  J Clin Invest       Date:  1998-09-15       Impact factor: 14.808

3.  Modulation of amplitude and direction of in vivo immune responses by co-administration of cytokine gene expression cassettes with DNA immunogens.

Authors:  J J Kim; N N Trivedi; L K Nottingham; L Morrison; A Tsai; Y Hu; S Mahalingam; K Dang; L Ahn; N K Doyle; D M Wilson; M A Chattergoon; A A Chalian; J D Boyer; M G Agadjanyan; D B Weiner
Journal:  Eur J Immunol       Date:  1998-03       Impact factor: 5.532

4.  DermaVir: a novel topical vaccine for HIV/AIDS.

Authors:  Julianna Lisziewicz; Jeffrey Trocio; Lucia Whitman; Georg Varga; Jianqing Xu; Nyasha Bakare; Patrick Erbacher; Cecil Fox; Ruth Woodward; Phil Markham; Suresh Arya; Jean-Paul Behr; Franco Lori
Journal:  J Invest Dermatol       Date:  2005-01       Impact factor: 8.551

5.  Cutting edge: requirement for IL-15 in the generation of primary and memory antigen-specific CD8 T cells.

Authors:  Kimberly S Schluns; Kristina Williams; Averil Ma; Xin X Zheng; Leo Lefrançois
Journal:  J Immunol       Date:  2002-05-15       Impact factor: 5.422

6.  Control of viral rebound through therapeutic immunization with DermaVir.

Authors:  Julianna Lisziewicz; Jeffrey Trocio; Jianqing Xu; Lucia Whitman; Amy Ryder; Nyasha Bakare; Mark G Lewis; Wendeline Wagner; Angela Pistorio; Suresh Arya; Franco Lori
Journal:  AIDS       Date:  2005-01-03       Impact factor: 4.177

7.  IL-15 expression plasmid enhances cell-mediated immunity induced by an HIV-1 DNA vaccine.

Authors:  K Q Xin; K Hamajima; S Sasaki; T Tsuji; S Watabe; E Okada; K Okuda
Journal:  Vaccine       Date:  1999-02-26       Impact factor: 3.641

8.  Potent and selective stimulation of memory-phenotype CD8+ T cells in vivo by IL-15.

Authors:  X Zhang; S Sun; I Hwang; D F Tough; J Sprent
Journal:  Immunity       Date:  1998-05       Impact factor: 31.745

9.  Interleukin-4 mediates down regulation of antiviral cytokine expression and cytotoxic T-lymphocyte responses and exacerbates vaccinia virus infection in vivo.

Authors:  D P Sharma; A J Ramsay; D J Maguire; M S Rolph; I A Ramshaw
Journal:  J Virol       Date:  1996-10       Impact factor: 5.103

10.  Differential immunogenicity of various heterologous prime-boost vaccine regimens using DNA and viral vectors in healthy volunteers.

Authors:  Jenni M Vuola; Sheila Keating; Daniel P Webster; Tamara Berthoud; Susanna Dunachie; Sarah C Gilbert; Adrian V S Hill
Journal:  J Immunol       Date:  2005-01-01       Impact factor: 5.422

View more
  21 in total

Review 1.  Technologies for enhanced efficacy of DNA vaccines.

Authors:  Fadi Saade; Nikolai Petrovsky
Journal:  Expert Rev Vaccines       Date:  2012-02       Impact factor: 5.217

2.  Interleukin-27 inhibits vaccine-enhanced pulmonary disease following respiratory syncytial virus infection by regulating cellular memory responses.

Authors:  Ruihong Zeng; Huixian Zhang; Yan Hai; Yuxiu Cui; Lin Wei; Na Li; Jianxun Liu; Caixia Li; Ying Liu
Journal:  J Virol       Date:  2012-02-01       Impact factor: 5.103

3.  RSV recombinant candidate vaccine G1F/M2 with CpG as an adjuvant prevents vaccine-associated lung inflammation, which may be associated with the appropriate types of immune memory in spleens and lungs.

Authors:  Na Li; Ling Zhang; Boyang Zheng; Wenjian Li; Jianxun Liu; Huixian Zhang; Ruihong Zeng
Journal:  Hum Vaccin Immunother       Date:  2019-04-29       Impact factor: 3.452

Review 4.  Functions of IL-15 in anti-viral immunity: multiplicity and variety.

Authors:  Katherine C Verbist; Kimberly D Klonowski
Journal:  Cytokine       Date:  2012-06-15       Impact factor: 3.861

5.  Expression of interleukin-15 and interleukin-15Rα in monocytes of HIV type 1-infected patients with different courses of disease progression.

Authors:  Maciej Tarkowski; Laurenzia Ferraris; Sara Martone; Francesco Strambio de Castillia; Donatella Misciagna; Renata I Mazzucchelli; Emanuela Lattuada; Giuseppe Paraninfo; Massimo Galli; Agostino Riva
Journal:  AIDS Res Hum Retroviruses       Date:  2011-09-23       Impact factor: 2.205

Review 6.  Viral vaccines and CTL response.

Authors:  Stacie N Woolard; Uday Kumaraguru
Journal:  J Biomed Biotechnol       Date:  2010-03-31

7.  Myxoma virus expressing interleukin-15 fails to cause lethal myxomatosis in European rabbits.

Authors:  Jia Liu; Sonia Wennier; Mary Reinhard; Edward Roy; Amy MacNeill; Grant McFadden
Journal:  J Virol       Date:  2009-03-11       Impact factor: 5.103

Review 8.  Application of nanotechnologies for improved immune response against infectious diseases in the developing world.

Authors:  Michael Look; Arunima Bandyopadhyay; Jeremy S Blum; Tarek M Fahmy
Journal:  Adv Drug Deliv Rev       Date:  2009-11-14       Impact factor: 15.470

Review 9.  Dendritic cell-based human immunodeficiency virus vaccine.

Authors:  C R Rinaldo
Journal:  J Intern Med       Date:  2009-01       Impact factor: 8.989

10.  Plasmid-encoded interleukin-15 receptor alpha enhances specific immune responses induced by a DNA vaccine in vivo.

Authors:  Kimberly A Kraynyak; Michele A Kutzler; Neil J Cisper; Dominick J Laddy; Matthew P Morrow; Thomas A Waldmann; David B Weiner
Journal:  Hum Gene Ther       Date:  2009-10       Impact factor: 5.695

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.